Eton Pharmaceuticals, Inc.ETONNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+75.1%
5Y CAGR+164.8%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+75.1%/yr
vs +223.9%/yr prior
5Y CAGR
+164.8%/yr
Recent deceleration
Acceleration
-148.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
130.1x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $37.21M | +138.5% |
| 2024 | $15.60M | +47.4% |
| 2023 | $10.58M | +52.6% |
| 2022 | $6.93M | +164.3% |
| 2021 | $2.62M | +817.1% |
| 2020 | $286000.00 | -36.9% |
| 2019 | $453000.00 | +619.0% |
| 2018 | $63000.00 | +384.6% |
| 2017 | $13000.00 | - |